EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+28.29%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$3.55B
AUM Growth
+$3.55B
(+17%)
Cap. Flow
-$53.8M
Cap. Flow
% of AUM
-1.51%
Top 10 Holdings %
Top 10 Hldgs %
31.77%
Holding
145
New
18
Increased
29
Reduced
10
Closed
28
Top Buys
| 1 |
Brookfield Renewable
BEP
|
$38.6M |
| 2 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$27.3M |
| 3 |
Trex
TREX
|
$26.9M |
| 4 |
Novanta
NOVT
|
$24.8M |
| 5 |
Dynatrace
DT
|
$20.9M |
Top Sells
| 1 |
TMX
Terminix Global Holdings, Inc.
TMX
|
$41.9M |
| 2 |
PEGI
Pattern Energy Group Inc. Class A
PEGI
|
$28.9M |
| 3 |
Sarepta Therapeutics
SRPT
|
$28.8M |
| 4 |
Arista Networks
ANET
|
$28M |
| 5 |
Galapagos
GLPG
|
$25.2M |
Sector Composition
| 1 | Healthcare | 46.72% |
| 2 | Technology | 21.45% |
| 3 | Industrials | 9.37% |
| 4 | Consumer Discretionary | 6.67% |
| 5 | Utilities | 3.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ascendis Pharma
ASND
$11.8B
| $236M | 6.66% | 1,698,648 | – | – |
|
|
ZGNX
2
DELISTED
Zogenix, Inc.
ZGNX
| $148M | 4.17% | 2,841,300 | – | – |
|
|
3
Sarepta Therapeutics
SRPT
$1.78B
| $129M | 3.62% | 996,000 -223,000 | -18% | -$28.8M |
|
4
Trade Desk
TTD
$26.7B
| $110M | 3.11% | 425,000 | – | – |
|
|
AIMT
5
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $103M | 2.91% | 3,084,000 | – | – |
|
|
BHVN
6
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $89M | 2.51% | 1,634,000 | – | – |
|
7
FIVE9
FIVN
$2.08B
| $82M | 2.31% | 1,250,000 | – | – |
|
8
Twilio
TWLO
$16.2B
| $81.3M | 2.29% | 827,000 | – | – |
|
9
Roper Technologies
ROP
$56.6B
| $75.8M | 2.14% | 214,000 | – | – |
|
10
Waste Connections
WCN
$47.5B
| $73M | 2.06% | 804,000 | – | – |
|
11
Lowe's Companies
LOW
$145B
| $70.7M | 1.99% | 590,400 +8,600 | +1% | +$1.03M |
|
12
Palo Alto Networks
PANW
$127B
| $66.4M | 1.87% | 287,000 | – | – |
|
|
SPLK
13
DELISTED
Splunk Inc
SPLK
| $64.1M | 1.81% | 428,000 | – | – |
|
|
MYOV
14
DELISTED
Myovant Sciences Ltd.
MYOV
| $64M | 1.8% | 4,126,131 -568,786 | -12% | -$8.83M |
|
15
Xylem
XYL
$34.5B
| $62.2M | 1.75% | 789,800 +2,700 | +0.3% | +$213K |
|
16
Lam Research
LRCX
$127B
| $58.8M | 1.66% | 201,000 -26,000 | -11% | -$7.6M |
|
17
Mettler-Toledo International
MTD
$26.8B
| $57.6M | 1.62% | 72,610 | – | – |
|
|
SAGE
18
DELISTED
Sage Therapeutics
SAGE
| $57M | 1.61% | 790,000 | – | – |
|
|
XIFR
19
XPLR Infrastructure, LP
XIFR
$996M
| $56.1M | 1.58% | 1,065,922 +2,000 | +0.2% | +$105K |
|
20
HubSpot
HUBS
$25.5B
| $55.5M | 1.56% | 350,000 | – | – |
|
21
ASML
ASML
$292B
| $53.5M | 1.51% | 180,900 +2,500 | +1% | +$740K |
|
22
Wayfair
W
$9.67B
| $51.8M | 1.46% | 573,000 | – | – |
|
23
Dianthus Therapeutics
DNTH
$759M
| $51.5M | 1.45% | 3,393,894 +438,462 | +15% | +$6.65M |
|
24
Collegium Pharmaceutical
COLL
$1.22B
| $50M | 1.41% | 2,427,976 | – | – |
|
25
Lennox International
LII
$19.6B
| $48.8M | 1.37% | 200,000 | – | – |
|